Ad Hoc percutaneous coronary intervention: A consensus statement from the society for cardiovascular angiography and interventions

Catheterization and Cardiovascular Interventions - Tập 81 Số 5 - Trang 748-758 - 2013
James C. Blankenship1, Osvaldo Gigliotti2, Dmitriy N. Feldman3, Timothy A. Mixon4, Rajan A.G. Patel5, Paul Sorajja6, Steven J. Yakubov7, Charles E. Chambers8
1Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania
2Seton Heart Institute Austin Texas
3Division of Cardiology, Weill Cornell Medical College, New York, New York.
4Department of Cardiology Texas A&M College of Medicine Temple Texas
5Department of Cardiology Ochsner Clinic Foundation New Orleans Los Angeles
6Department of Cardiology, Mayo Clinic, Rochester, Minnesota
7Ohio Health Research Institute Riverside Methodist Hospital Columbus Ohio
8Department of Cardiology Hershey Medical Center Hershey Pennsylvania

Tóm tắt

Percutaneous coronary interventions (PCI) may be performed during the same session as diagnostic catheterization (ad hoc PCI) or at a later session (delayed PCI). Randomized trials comparing these strategies have not been performed; cohort studies have not identified consistent differences in safety or efficacy between the two strategies. Ad hoc PCI has increased in prevalence over the past decade and is the default strategy for treating acute coronary syndromes. However, questions about its appropriateness for some patients with stable symptoms have been raised by the results of recent large trials comparing PCI to medical therapy or bypass surgery. Ad hoc PCI for stable ischemic heart disease requires preprocedural planning, and reassessment after diagnostic angiography must be performed to ensure its appropriateness. Patients may prefer ad hoc PCI because it is convenient. Payers may prefer ad hoc PCI because it is cost‐efficient. The majority of data confirm equivalent outcomes in ad hoc versus delayed PCI. However, there are some situations in which delayed PCI may be safer or yield better outcomes. This document reviews patient subsets and clinical situations in which one strategy is preferable over the other. © 2012 Wiley Periodicals, Inc.

Từ khóa


Tài liệu tham khảo

10.1001/archinternmed.2011.2313

10.1161/CIR.0b013e31823a5596

10.1016/j.jacc.2011.12.001

10.1002/ccd.20229

10.1002/ccd.1810120404

10.1002/ccd.1810120402

10.1177/000331979104200802

10.1016/0002-9149(89)91070-9

10.1016/0002-8703(91)90757-9

10.1055/s-2008-1058676

10.1016/S0002-9149(99)80522-0

10.1016/S0735-1097(97)00149-6

10.1034/j.1600-0854.2003.8045.x

10.1002/clc.4960230505

10.1016/S0002-9149(00)00826-2

10.1016/S0002-8703(02)00123-0

10.1016/j.amjcard.2006.09.093

10.1002/ccd.20910

10.1016/j.jcin.2009.01.006

Good CW, 2009, Feasibility and safety of ad hoc percutaneous coronary intervention in the modern era, J Invasive Cardiol, 21, 194

10.1016/j.jacc.2010.03.007

10.1056/NEJMoa070829

10.1056/NEJMoa0804626

10.1001/jama.2010.1509

10.1002/ccd.23353

10.1016/0735-1097(88)90431-7

10.1016/S0735-1097(01)01344-4

10.1056/NEJMoa0807611

10.1016/j.jacc.2007.01.087

10.1016/j.jacc.2011.03.046

10.1001/jama.295.21.2511

10.1016/S0735-1097(03)01050-7

10.1161/CIRCULATIONAHA.106.613596

10.1161/01.CIR.0000025609.13806.31

10.1016/j.jacc.2006.10.054

10.1016/j.ahj.2004.03.026

Palmer ND, 2004, Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention, J Invasive Cardiol, 16, 185

10.1016/j.jcin.2010.09.005

10.1016/j.jcin.2011.02.013

10.1161/CIRCINTERVENTIONS.110.959148

10.1016/j.jcin.2009.12.010

10.1002/ccd.23353

10.1016/j.amjcard.2008.06.059

10.1016/j.jacc.2004.06.068

10.1016/j.jacc.2007.03.058

10.1001/archderm.143.5.637

10.1002/ccd.22867

10.1016/j.jcin.2012.01.004

10.1161/CIRCOUTCOMES.108.791863

10.1016/j.jacc.2010.02.005

10.1016/j.jacc.2011.06.020

10.1161/01.CIR.0000160869.75810.98

MontalescotG WiviottSD BraunwaldE MurphySA GibsonCM McCabeCH AntmanEM.Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST‐elevation myocardial infarction (TRITON‐TIMI 38): Double‐blind randomised controlled trial.2009;373:723–731.

10.1093/eurheartj/ehr501

10.1016/S0735-1097(97)00512-3